Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 3 studies | 17% ± 1% | |
epithelial cell | 3 studies | 25% ± 7% |
Insufficient scRNA-seq data for expression of PEX19 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4211.31 | 2642 / 2642 | 100% | 56.93 | 705 / 705 |
esophagus | 100% | 4074.40 | 1445 / 1445 | 100% | 33.34 | 183 / 183 |
liver | 100% | 4517.08 | 226 / 226 | 100% | 60.08 | 406 / 406 |
ovary | 100% | 4743.62 | 180 / 180 | 100% | 51.48 | 430 / 430 |
thymus | 100% | 4700.47 | 653 / 653 | 100% | 66.08 | 604 / 605 |
intestine | 100% | 4111.10 | 966 / 966 | 100% | 29.04 | 526 / 527 |
bladder | 100% | 4651.76 | 21 / 21 | 100% | 45.58 | 503 / 504 |
prostate | 100% | 4386.56 | 245 / 245 | 100% | 51.80 | 501 / 502 |
skin | 100% | 3944.68 | 1809 / 1809 | 100% | 52.12 | 471 / 472 |
uterus | 100% | 4250.52 | 170 / 170 | 100% | 39.49 | 458 / 459 |
lung | 100% | 3436.59 | 577 / 578 | 100% | 40.28 | 1154 / 1155 |
breast | 100% | 6962.43 | 459 / 459 | 100% | 66.40 | 1115 / 1118 |
stomach | 100% | 3334.59 | 359 / 359 | 100% | 28.86 | 285 / 286 |
kidney | 100% | 4469.19 | 89 / 89 | 99% | 39.62 | 894 / 901 |
adrenal gland | 100% | 5295.07 | 258 / 258 | 98% | 54.00 | 225 / 230 |
pancreas | 95% | 1421.41 | 313 / 328 | 99% | 33.15 | 176 / 178 |
adipose | 100% | 7448.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4730.63 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 42.47 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 33.12 | 29 / 29 |
muscle | 100% | 4733.19 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3079.06 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 31.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.38 | 1 / 1 |
heart | 97% | 3931.68 | 834 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 2226.34 | 861 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1900131 | Biological process | negative regulation of lipid binding |
GO_0061077 | Biological process | chaperone-mediated protein folding |
GO_0045046 | Biological process | protein import into peroxisome membrane |
GO_0050821 | Biological process | protein stabilization |
GO_0007031 | Biological process | peroxisome organization |
GO_0016559 | Biological process | peroxisome fission |
GO_0072663 | Biological process | establishment of protein localization to peroxisome |
GO_0006625 | Biological process | protein targeting to peroxisome |
GO_0031526 | Cellular component | brush border membrane |
GO_0005778 | Cellular component | peroxisomal membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005777 | Cellular component | peroxisome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0036105 | Molecular function | peroxisome membrane class-1 targeting sequence binding |
GO_0140597 | Molecular function | protein carrier chaperone |
GO_0051117 | Molecular function | ATPase binding |
GO_0033328 | Molecular function | peroxisome membrane targeting sequence binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PEX19 |
Protein name | Peroxisomal biogenesis factor 19 (33 kDa housekeeping protein) (Peroxin-19) (Peroxisomal farnesylated protein) Peroxisomal biogenesis factor 19 Peroxisomal biogenesis factor 19 (Peroxin-19) (Peroxisomal farnesylated protein) |
Synonyms | HK33 hCG_39731 PXF OK/SW-cl.22 |
Description | FUNCTION: Necessary for early peroxisomal biogenesis. Acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Binds and stabilizes newly synthesized PMPs in the cytoplasm by interacting with their hydrophobic membrane-spanning domains, and targets them to the peroxisome membrane by binding to the integral membrane protein PEX3. Excludes CDKN2A from the nucleus and prevents its interaction with MDM2, which results in active degradation of TP53. . FUNCTION: Necessary for early peroxisomal biogenesis. Acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Binds and stabilizes newly synthesized PMPs in the cytoplasm by interacting with their hydrophobic membrane-spanning domains, and targets them to the peroxisome membrane by binding to the integral membrane protein PEX3. Excludes CDKN2A from the nucleus and prevents its interaction with MDM2, which results in active degradation of TP53. . FUNCTION: Necessary for early peroxisomal biogenesis. Acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Binds and stabilizes newly synthesized PMPs in the cytoplasm by interacting with their hydrophobic membrane-spanning domains, and targets them to the peroxisome membrane by binding to the integral membrane protein PEX3. Excludes CDKN2A from the nucleus and prevents its interaction with MDM2, which results in active degradation of TP53. . FUNCTION: Necessary for early peroxisomal biogenesis. Acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Binds and stabilizes newly synthesized PMPs in the cytoplasm by interacting with their hydrophobic membrane-spanning domains, and targets them to the peroxisome membrane by binding to the integral membrane protein PEX3. Excludes CDKN2A from the nucleus and prevents its interaction with MDM2, which results in active degradation of TP53. . FUNCTION: Necessary for early peroxisomal biogenesis. Acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Binds and stabilizes newly synthesized PMPs in the cytoplasm by interacting with their hydrophobic membrane-spanning domains, and targets them to the peroxisome membrane by binding to the integral membrane protein PEX3. Excludes CDKN2A from the nucleus and prevents its interaction with MDM2, which results in active degradation of TP53. . |
Accessions | P40855 A0A0S2Z497 Q5QNY5 ENST00000462644.5 ENST00000532643.5 ENST00000495624.1 ENST00000472750.5 [P40855-6] E9PS71 B7Z6I5 B7Z8B3 ENST00000392220.2 ENST00000368072.10 [P40855-1] H0YDY4 |